TNFD launches framework on nature-related risk reporting; recommends voluntary market adoption
British drugmaker GSK is the first company to commit to guidelines from the Taskforce on Nature-related Financial Disclosures, which will begin tracking adoption annually from 2024 onwards.
19
September
2023
British drugmaker GSK is the first company to commit to guidelines from the Taskforce on Nature-related Financial Disclosures, which will begin tracking adoption annually from 2024 onwards.
